MEXAPAN-D

MEXAPAN-DTM contains Pantoprazole 40 mg and Domperidone 10 mg and is used under medical supervision for selected acid-related gastrointestinal symptoms with nausea or vomiting.

📋 COMPOSITION
Pantoprazole 40 mg & Domperidone 10 mg

💊 DOSAGE FORM
Tablets

📦 PACKAGING TYPE
ALU-ALU

🗃️ PACKAGING
10 × 10 Tablets

Description

MEXAPAN-DTM contains Pantoprazole 40 mg and Domperidone 10 mg, a combination used under medical supervision for selected acid-related and upper gastrointestinal symptoms where acid suppression and control of nausea or vomiting are both clinically appropriate. Pantoprazole reduces gastric acid production, while Domperidone helps improve upper gastrointestinal motility and has anti-nausea effects.

For related tablet formulations and gastrointestinal products, Medhexa Pharma Tablets can be referred to for additional product information.

Therapeutic Segment

Gastrointestinal Care | Proton Pump Inhibitors | Antiemetics

Uses of MEXAPAN-DTM

MEXAPAN-DTM may be prescribed for selected gastrointestinal symptoms involving:

  • Acid-related gastrointestinal symptoms
  • Heartburn associated with acid reflux
  • Gastroesophageal reflux symptoms when appropriate
  • Nausea or vomiting associated with certain gastrointestinal conditions
  • Upper gastrointestinal discomfort where both acid suppression and improved gastric motility are required

Pantoprazole reduces stomach acid, while Domperidone acts on gastrointestinal motility and can help control nausea and vomiting. However, the exact indication should be determined by a healthcare professional.

Key Benefits of Pantoprazole and Domperidone

  • Contains Pantoprazole 40 mg
  • Contains Domperidone 10 mg
  • Combines acid suppression with prokinetic and anti-nausea activity
  • Helps manage selected acid-related gastrointestinal symptoms
  • Available in convenient tablet form
  • Supplied in 10 × 10 ALU-ALU packaging

How MEXAPAN-DTM Works

Pantoprazole belongs to the proton pump inhibitor (PPI) group. It blocks the gastric proton pump involved in the final stage of stomach acid secretion. Therefore, it reduces gastric acid production and helps create a less acidic environment in the stomach and upper digestive tract.

Domperidone works mainly by blocking dopamine receptors and increasing upper gastrointestinal motility. As a result, it can support gastric emptying and help reduce nausea and vomiting in appropriate patients.

Together, these ingredients address different aspects of selected gastrointestinal symptoms.

Common Side Effects of Pantoprazole and Domperidone

Some people may experience:

  • Headache
  • Nausea
  • Diarrhea
  • Constipation
  • Abdominal discomfort
  • Dry mouth
  • Dizziness
  • Weakness or tiredness

However, side effects can vary between individuals. Domperidone also carries specific cardiac safety concerns, including QT-interval prolongation and potentially serious heart-rhythm disturbances.

Important Safety Information

Use MEXAPAN-DTM only according to the advice of a doctor or pharmacist.

In particular, tell your healthcare professional if you have heart disease, an abnormal heart rhythm, prolonged QT interval, electrolyte abnormalities, significant liver disease or kidney problems. Domperidone should not be used in patients with certain cardiac conditions or together with medicines that can prolong the QT interval or strongly inhibit CYP3A4.

Also, Domperidone should generally be used at the lowest effective dose for the shortest possible duration. European regulatory guidance recommends that treatment should normally not exceed one week for its authorised anti-nausea indication.

Pantoprazole may interact with certain medicines, and long-term PPI treatment can have effects such as vitamin B12 deficiency, low magnesium levels and increased fracture risk in some patients. Therefore, tell your doctor about all medicines and supplements you take, particularly if prolonged treatment is planned.

Pantoprazole is contraindicated in patients with hypersensitivity to pantoprazole or substituted benzimidazoles, and current prescribing information also lists concomitant use with rilpivirine-containing products as a contraindication.

Seek urgent medical attention if you experience fainting, rapid or irregular heartbeat, difficulty breathing, facial or throat swelling, severe skin reactions, or other serious symptoms.

For additional information on Domperidone safety, refer to the European Medicines Agency guidance on Domperidone-containing medicines.

Dosage & Administration

The appropriate dose and treatment duration depend on the patient’s condition, age, medical history and other medicines being taken. Therefore, take MEXAPAN-DTM only in the dose and duration prescribed by your healthcare professional.

Pantoprazole delayed-release tablets should generally be swallowed whole and should not be crushed or chewed. The exact administration instructions can depend on the formulation and prescribing information for the product.

Because Domperidone requires specific dose and duration precautions, do not increase the dose or continue treatment for longer than recommended.

If you miss a dose, follow your doctor’s or pharmacist’s instructions. Do not take a double dose to compensate for a missed dose.

Storage

  • Store MEXAPAN-DTM in a cool and dry place.
  • Protect the tablets from excessive heat and moisture.
  • Keep the tablets in their original packaging until use.
  • Keep out of reach of children.
  • Follow the storage instructions printed on the product packaging.

Additional information

Packing